-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Article source: Medical Rubik's Cube Info
Author: Sunshine
On December 22, the official website of CDE showed that the marketing application of Livzon Pharmaceutical Tocilizumab was accepted by the State Food and Drug Administration
Tocilizumab injection (tocilizumab) was developed by Chugai Pharmaceutical (Roche).
Since February 2009, tocilizumab has been approved for marketing in many countries and regions such as the European Union, the United States, Japan, and China.
Source: NextPharma
At present, there are 3 indications approved in China for the research of tocilizan antigen, namely: adult rheumatoid arthritis, systemic juvenile idiopathic arthritis and cytokine release syndrome